Development of Antifungals of Clinical Importance

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$162,637.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI058439-01
Agency Tracking Number:
AI058439
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
SYNVAX, INC.
SYNVAX, INC., 1770 N RESEARCH PKWY, STE 125, NORTH LOGAN, UT, 84341
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
AMRIT Judd
(435) 713-4917
SYNVAX@AOL.COM
Business Contact:
AMRIT JUDD
(435) 713-4917
SYNVAX@AOL.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Fungal infections have increased dramatically in recent years to become important causes of mortality in hospitalized patients. The increase in life-threatening fungal infections has brought about an increased use of

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government